Increased ALLY® Adaptive Cataract Treatment System installed base to 28 systems with a backlog of 6 additional systems for installation…
Landmark Phase 1a/2b clinical trial of NVG-291 proceeds with recruitment of individuals with spinal cord injury; results expected in mid-2024…
Funding for Phase 1, 2, and 3 trials sought to develop NP-300 to increase American preparedness and response time in…
The Collaboration Signals Era of New Innovation for AI Nose Technology for Broader Industry AdoptionWith Partnership, Ainos Makes Progress Towards…
Estimated cash runway now extended through Q1 2026NEWARK, CA / ACCESSWIRE / August 9, 2023 / Protagonist Therapeutics (NASDAQ:PTGX) ("Protagonist"…
Financials for First Quarter Fiscal Year 2024 Ended June 30, 2023 will be released on August 14, 2023NORTHVALE, NJ /…
VANCOUVER, BC / ACCESSWIRE / August 9, 2023 / Empower Clinics Inc. ("Empower" or the "Company") (CSE:EPW)(OTC PINK:EPWCF), is pleased…
Eric Jaworsky brings a wealth of knowledge in the fitness industry as the company continues to growCLEARWATER, Fla., Aug. 09,…
interRAI: Speaking one language for high quality care worldwide WATERLOO, Ontario, Aug. 09, 2023 (GLOBE NEWSWIRE) -- In a recently-published…
Cutting-edge AI/machine learning technology with validation in humans for early diagnosis of lung cancer In silico detection for 12 additional…